Synthesis and biological evaluation of 2‐benzylaminoquinazolin‐4(3H)‐one derivatives as a potential treatment for SARS‐CoV‐2

MLA

Lee, Jun Young, et al. “Synthesis and Biological Evaluation of 2‐benzylaminoquinazolin‐4(3H)‐one Derivatives as a Potential Treatment for SARS‐CoV‐2.” Bulletin of the Korean Chemical Society, vol. 43, no. 3, Mar. 2022, pp. 412–16. EBSCOhost, https://doi.org/10.1002/bkcs.12470.

APA

Lee, J. Y., Shin, Y. S., Jeon, S., Lee, S. I., Cho, J., Myung, S., Jang, M. S., Kim, S., Song, J. H., Kim, H. R., & Park, C. M. (2022). Synthesis and biological evaluation of 2‐benzylaminoquinazolin‐4(3H)‐one derivatives as a potential treatment for SARS‐CoV‐2. Bulletin of the Korean Chemical Society, 43(3), 412–416. https://doi.org/10.1002/bkcs.12470

Chicago

Lee, Jun Young, Young Sup Shin, Sangeun Jeon, Se In Lee, Jung‐Eun Cho, Subeen Myung, Min Seong Jang, et al. 2022. “Synthesis and Biological Evaluation of 2‐benzylaminoquinazolin‐4(3H)‐one Derivatives as a Potential Treatment for SARS‐CoV‐2.” Bulletin of the Korean Chemical Society 43 (3): 412–16. doi:10.1002/bkcs.12470.